Revvity | PKI - Operating Profit


Revvity reported $126.14M in Operating Profit for its fiscal quarter ending in June of 2026.





Operating Profit Change Date
Agilent USD 399M 46M Mar/2026
Align Technology USD 191.32M 13.27M Jun/2026
Bio Techne USD 75.49M 21.03M Mar/2026
Bio-Rad Laboratories USD 72.6M 38.5M Jun/2026
Bruker USD 69.6M 59.4M Jun/2026
Celltrion KRW 12.9B 822.77M Mar/2026
Charles River Laboratories USD 119.89M 9K Jun/2026
Cspc Pharmaceutical CNY 206.26M 1.02B Dec/2025
Danaher USD 1.13B 217M Jun/2026
Dentsply International USD 32M 506M Mar/2026
Deva Holding AS TRY 964.87M 240.32M Sep/2023
Dianthus Therapeutics USD -46.53M 23.01M Mar/2026
Divis Laboratories Ltd INR 11.29B 3.15B Jun/2026
Edwards Lifesciences USD 519.5M 4.8M Jun/2026
Illumina USD 260M 21M Jun/2026
Intuitive Surgical USD 977.6M 117.9M Jun/2026
IQVIA Holdings USD 2.6B 2.03B Jun/2026
Kangmei Pharma CNY -10.94M 15.75M Mar/2026
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Laboratorios Farma EUR 135.05M 49.84M Dec/2023
Laboratory Of America USD 456.7M 46.6M Jun/2026
Malin Corporation EUR -1.1M 400K Dec/2024
Medical Developments International AUD -36K 444K Dec/2025
Mesa Laboratories USD 5.78M 2.27M Dec/2024
Mettler Toledo International USD 287.55M 53.61M Jun/2026
Myriad Genetics USD -3M 20.3M Dec/2025
Neuren Pharmaceuticals AUD 17.01M 11.56M Dec/2025
OraSure Technologies USD -13.59M 2.13M Dec/2025
Organigram Holdings CAD -9.79M 10.33M Mar/2026
Ovoca Bio EUR -173K 990K Dec/2025
Pacific Biosciences Of California USD -53.19M 35.08M Dec/2025
Pharma Mar EUR -1.4M 2.03M Jun/2026
Qiagen NV USD 116.63M 5.25M Mar/2026
Quest Diagnostics USD 459M 60M Jun/2026
Quidel USD -31.8M 5.5M Mar/2026
Repligen USD 21.13M 1.15M Jun/2026
Revvity USD 126.14M 43.36M Jun/2026
Sartorius EUR 164M 3.3M Jun/2026
Sino Biopharmaceutical CNY 5.18B 3.32B Jun/2025
Thermo Fisher Scientific USD 2.18B 273M Jun/2026
Tilray USD -20.01M 9.34M Sep/2025
Waters USD -86M 234M Jun/2026
Zealand Pharma A/S -539M 168.05M Mar/2026
Zz Pientze Pharmaceu CNY 837.81M 336.48M Mar/2026